You are here
Vertex Announces New $750,000 Program to Support the Work of the Next Generation of Cystic Fibrosis Researchers
The Vertex Research Innovation Award (RIA) Program Will Now Provide up to $10M in Grants Over the Next Five Years to New Postdoctoral and Faculty Researchers from Around the World.
November 1, 2017
Three years ago, Vertex launched the CF RIA Awards, highly competitive grants created to inspire and support M.D.s and Ph.Ds. who are working to advance the understanding of CF and establish their careers as CF researchers.
Today Vertex introduced a new $750,000 program to support the work of young faculty who are newly establishing independent research programs in CF. The program furthers Vertex’s support for the next generation of CF researchers by expanding the existing CF Research Innovation Awards (RIA) program, which supports the work of postdoctoral researchers. Applicants from across the globe are welcome to apply now through January 8, 2018. Together, these programs will provide up to $10 million in grants over the next five years and are part of Vertex’s recently announced 10-year, $500 million corporate giving commitment.
The awards fall into two categories: Independent and Mentored.
Independent Research Innovation Awards provide grants of $750,000 dispersed over three years to support newly independent faculty members as they establish their own research programs with outstanding promise in CF. Up to two awards will be given annually in this category.
Mentored Research Innovation Awards provide grants of up to $125,000 dispersed over two years to support mentored projects with established CF researchers. Up to four awards in this category will be given annually.
“Vertex invests in science to create transformative medicines for people with serious diseases, and the next generation of scientists are needed to make this vision a reality,” said David Altshuler, M.D., Ph.D., Executive Vice President, Global Research and Chief Scientific Officer of Vertex. “Supporting the development of young physician researchers and scientists is critical to continued advancement of our understanding of the disease, and to ensure people living with cystic fibrosis have the best care for the future.”
Reviewed and selected by an independent steering committee, applications are now being accepted until January 8, 2018. For additional information and to apply please visit www.cfresearchinnovationaward.com.